1. The genetics of testosterone contributes to 'femaleness/maleness' of cardiometabolic traits and type 2 diabetes
- Author
-
Nadine Parker, Daniel E. Vosberg, Tomáš Paus, Jean Shin, and Zdenka Pausova
- Subjects
Adult ,Male ,Metabolic Syndrome ,Cardiometabolic risk ,Sex Differentiation ,Nutrition and Dietetics ,Endocrinology, Diabetes and Metabolism ,Medicine (miscellaneous) ,Physiology ,Testosterone (patch) ,Type 2 diabetes ,Middle Aged ,Biology ,medicine.disease ,Obesity ,Genetic architecture ,Diabetes Mellitus, Type 2 ,Bioavailable Testosterone ,medicine ,Humans ,Female ,Genetic Predisposition to Disease ,Testosterone ,Genome-Wide Association Study ,Genetic association - Abstract
The genetic architecture of testosterone is highly distinct between sexes. Moreover, obesity is associated with higher testosterone in females but lower testosterone in males. Here, we ask whether male-specific testosterone variants are associated with a male pattern of obesity and type 2 diabetes (T2D) in females, and vice versa. In the UK Biobank, we conducted sex-specific genome-wide association studies and computed polygenic scores for total (PGSTT) and bioavailable testosterone (PGSBT). We tested sex-congruent and sex-incongruent associations between sex-specific PGSTs and metabolic traits, as well as T2D diagnosis. Female-specific PGSBT was associated with an elevated cardiometabolic risk and probability of T2D, in both sexes. Male-specific PGSTT was associated with traits conferring a lower cardiometabolic risk and probability of T2D, in both sexes. We demonstrate the value in considering polygenic testosterone as sex-related continuous traits, in each sex.
- Published
- 2021